CD4 and graft versus host disease: It was reported that human placenta-derived mesenchymal stromal cells (hPMSCs) could improve GVHD by increasing the proportion of Th2 and CD4+CD25+FoxP3+ T cells via PD-L1 expressed on the hPMSC surface and by subsequently alleviating liver damage [1, 2].